Franz, J., Mikhael, J., Mehta, D., Choksi, R., Salman, T., Gart, M., Li, J., Dave, H., Kunst, L., Henn, K., Jain, P., Wang, B., Varughese, P., Morere, L., Scott, J., Richardson, P. (2025). Factors impacting treatment choice with a CD38 antibody, immunomodulator, proteasome inhibitor, and dexamethasone in first line multiple myeloma patients: A real-world US study. Blood. https://doi.org/10.1182/blood-2025-3988